Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Saini, Kamal S.; Lanza, Carlo; Romano, Marco; de Azambuja, Evandro; Cortés Castan, Javier; de las Heras, Begoña

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Saini, Kamal S.
dc.contributor.author	Lanza, Carlo
dc.contributor.author	Romano, Marco
dc.contributor.author	de Azambuja, Evandro
dc.contributor.author	Cortés Castan, Javier
dc.contributor.author	de las Heras, Begoña
dc.date.accessioned	2021-10-21T09:29:58Z
dc.date.available	2021-10-21T09:29:58Z
dc.date.issued	2020-09
dc.identifier.citation	Saini KS, Lanza C, Romano M, de Azambuja E, Cortes J, de Las Heras B, et al. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. Br J Cancer. 2020 Sep;123:694–697.
dc.identifier.issn	1532-1827
dc.identifier.uri	https://hdl.handle.net/11351/6429
dc.description	Desenvolupament de fàrmacs; Infecció viral
dc.language.iso	eng
dc.publisher	Springer Nature
dc.relation.ispartofseries	British Journal of Cancer;123
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	COVID-19 (Malaltia)
dc.subject	Medicaments antineoplàstics - Ús terapèutic
dc.subject.mesh	Coronavirus Infections
dc.subject.mesh	Antineoplastic Agents
dc.subject.mesh	/therapeutic use
dc.subject.mesh	Drug Repositioning
dc.title	Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41416-020-0948-x
dc.subject.decs	infecciones por Coronavirus
dc.subject.decs	antineoplásicos
dc.subject.decs	/uso terapéutico
dc.subject.decs	nuevas indicaciones de medicamentos
dc.relation.publishversion	https://doi.org/10.1038/s41416-020-0948-x
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Saini KS] Covance Inc, Princeton, NJ, USA. East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK. [Lanza C, Romano M] Covance Inc, Princeton, NJ, USA. [de Azambuja E] Institut Jules Bordet, Brussels, Belgium. Université Libre de Bruxelles (U.L.B), Brussels, Belgium. [Cortes J] IOB Institute of Oncology, Quiron Group, Madrid, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Medica Scientia Innovation Research, Ridgewood, NJ, USA. [de Las Heras B] Covance Inc, Princeton, NJ, USA. Madrid Medical Doctors Association, Madrid, Spain
dc.identifier.pmid	32572174
dc.identifier.wos	000542071100001
dc.rights.accessrights	info:eu-repo/semantics/openAccess